Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
- PMID: 34161817
- PMCID: PMC8214908
- DOI: 10.1016/j.jinf.2021.06.017
Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
Keywords: Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine.
Conflict of interest statement
Conflicts of Competing Interest The authors have no relevant competing interest to disclose in relation to this work.
Figures

Comment in
-
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.J Infect. 2021 Aug;83(2):e4-e5. doi: 10.1016/j.jinf.2021.06.024. Epub 2021 Jun 30. J Infect. 2021. PMID: 34214516 Free PMC article. No abstract available.
-
Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination.J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.07.001. Epub 2021 Jul 4. J Infect. 2022. PMID: 34233149 Free PMC article. No abstract available.
-
Post-SARS-CoV-2 vaccination specific antibody decrease : Let's get the half-full glass perspective.J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.07.027. Epub 2021 Jul 29. J Infect. 2022. PMID: 34332018 Free PMC article. No abstract available.
-
Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine.J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.008. Epub 2021 Aug 8. J Infect. 2022. PMID: 34371075 Free PMC article. No abstract available.
-
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine.J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.026. Epub 2021 Nov 2. J Infect. 2022. PMID: 34740744 Free PMC article. No abstract available.
Comment on
-
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.023. Epub 2021 May 27. J Infect. 2021. PMID: 34052240 Free PMC article.
References
-
- Capetti AF, Borgonovo F, Mileto D, Gagliardi G, Mariani C, Lupo A, et al. One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG. J Infect. 2021 doi: 10.1016/j.jinf.2021.05.023. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous